nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-421Research ArticleВСЕМИРНЫЙ ДЕНЬ ПОЧКИ 2016Сосредоточим внимание на детстве, предотвратим последствия болезней почекAverting the legacy of kidney disease - focus on childhoodИнгелфингерДжулияIngelfingerJulie Rmyriam@worldkidneyday.orgКалантар-ЗадеКамьярKalantar-ZadehKamyarmyriam@worldkidneyday.orgШеферФранцSchaeferFranzmyriam@worldkidneyday.orgМеждународное Общество НефрологовРоссияInternational Society of NephrologyRussian Federation2016190820241811018Copyright © Ингелфингер Д.R., Калантар-Заде К., Шефер Ф., 20242024Ингелфингер Д., Калантар-Заде К., Шефер Ф.Ingelfinger J.R., Kalantar-Zadeh K., Schaefer F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/421

От имени Организационного Комитета Всемирного Дня Почки * * Члены Организационного Комитета Всемирного Дня Почки: Филип Ли, Гиермо Гарсиа-Гарсиа, Уильям Каузер, Тимур Эрк, Джулия Ингерфилд, Камьяр Калантар-Заде, Чарльз Кернан, Шаролотта Осафо, Мигуэль Риелла, Лука Сегантини, Елена Захарова Перевод с английского Л.С. Приходиной под редакцией Е.В. Захаровой Перевод осуществлен по инициативе Российского Диализного Общества и одобрен Организационным Комитетом Всемирного Дня Почки Резюме Всемирный День Почки 2016 посвящен заболеваниям почек детского возраста и болезням почек у взрослых, начинающимся в раннем детстве. Спектр хронических болезней почек (ХБП) в детском возрасте, в отличие от взрослых, характеризуется преобладанием группы врожденных аномалий и наследственных заболеваний, в то время как гломерулопатии и поражения почек, обусловленные сахарным диабетом, встречаются относительно редко. Кроме того, у многих детей с острым почечным повреждением (ОПП) последствия ОПП в конечном итоге могут привести к гипертензии и ХБП, развивающимся в позднем детском возрасте или во взрослой жизни. У детей, рожденных преждевременно или с малой для гестационного возраста массой тела, повышен относительный риск развития ХБП в будущем. Лица с высоким риском развития болезней почек с рождения или с детства требуют тщательного наблюдения с целью своевременного выявления ранних признаков заболеваний почек и проведения эффективной профилактики или лечения. Успешное лечение возможно даже у детей с далеко зашедшей ХБП; убедительно показано, что у детей, по сравнению с взрослыми пациентами, результаты заместительной почечной терапии (ЗПТ), включая диализ и трансплантацию почки, лучше, при том, что лишь меньшинство детей нуждаются в этих видах терапии. Поскольку имеются различия в доступности медицинской помощи, необходимы совместные усилия по обеспечению эффективной терапии всем детям с заболеваниями почек независимо от их места проживания, географических и экономических условий. Мы надеемся, что Всемирный день почки даст общественности, политикам и всем, кто обеспечивает уход за детьми, необходимую информацию о потребностях и возможностях, связанных с лечением заболеваний почек в детском возрасте.

On behalf of the World Kidney Day Steering Committee * * Members of the World Kidney Day Steering Committee are: Philip Kam Tao Li, Guillermo Garcia-Garcia, William G. Couser, Timur Erk, Julie R Ingelfinger, Kamyar Kalantar-Zadeh, Charles Kernahan, Charlotte Osafo, Miguel C. Riella, Luca Segantini, Elena Zakharova Abstract World Kidney Day 2016 focuses on kidney disease in childhood and the antecedents of adult kidney disease that can begin in earliest childhood. Chronic kidney disease (CKD) in childhood differs from that in adults, as the largest diagnostic group among children includes congenital anomalies and inherited disorders, with glomerulopathies and kidney disease in the setting of diabetes being relatively uncommon. In addition, many children with acute kidney injury will ultimately develop sequelae that may lead to hypertension and CKD in later childhood or in adult life. Children born early or who are small for date newborns have relatively increased risk for the development of CKD later in life. Persons with a high-risk birth and early childhood history should be watched closely in order to help detect early signs of kidney disease in time to provide effective prevention or treatment. Successful therapy is feasible for advanced CKD in childhood; there is evidence that children fare better than adults, if they receive kidney replacement therapy including dialysis and transplantation, while only a minority of children may require this ultimate intervention. Because there are disparities in access to care, effort is needed so that those children with kidney disease, wherever they live, may be treated effectively, irrespective of their geographic or economic circumstances. Our hope is that World Kidney Day will inform the general public, policy makers and caregivers about the needs and possibilities surrounding kidney disease in childhood.

ReferencesGoldstein, S.L. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 33, 131-137 (2012).Goldstein, S.L. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 33, 131-137 (2012).Harambat, J., van Stralen, K.J., Kim, J.J. & Tizard, E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27, 363-373 (2012).Harambat, J., van Stralen, K.J., Kim, J.J. & Tizard, E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27, 363-373 (2012).Warady, B.A. & Chadha, V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol 22, 1999-2009 (2007).Warady, B.A. & Chadha, V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol 22, 1999-2009 (2007).Furth, S.L., et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1, 1006-1015 (2006).Furth, S.L., et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1, 1006-1015 (2006).Health statistics and information systems: Estimates for 2000-2012. http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.Health statistics and information systems: Estimates for 2000-2012. http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.NAPRTCS Annual Reports https://web.emmes.com/study/ped/annlrept/annlrept.html.NAPRTCS Annual Reports https://web.emmes.com/study/ped/annlrept/annlrept.html.Saran, R., et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 65, A7 (2015).Saran, R., et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 65, A7 (2015).ESPN/ERA-EDTA Registry, European Registry for Children on Renal Replacement Therapy http://www.espn-reg.org/index.jsp.ESPN/ERA-EDTA Registry, European Registry for Children on Renal Replacement Therapy http://www.espn-reg.org/index.jsp.Ardissino, G., et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111, e382-387 (2003).Ardissino, G., et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111, e382-387 (2003).Wong, C.J., Moxey-Mims, M., Jerry-Fluker, J., Warady, B.A. & Furth, S.L. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60, 1002-1011 (2012).Wong, C.J., Moxey-Mims, M., Jerry-Fluker, J., Warady, B.A. & Furth, S.L. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60, 1002-1011 (2012).Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 386, 743-800 (2013).Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 386, 743-800 (2013).Coca, S.G., Singanamala, S. & Parikh, C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81, 442-448 (2012).Coca, S.G., Singanamala, S. & Parikh, C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81, 442-448 (2012).Basu, R.K., et al. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16, 24 (2015).Basu, R.K., et al. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16, 24 (2015).Eckardt, K.U., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158-169 (2013).Eckardt, K.U., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158-169 (2013).Wuhl, E., et al. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8, 67-74 (2013).Wuhl, E., et al. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 8, 67-74 (2013).Group, E.T., et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361, 1639-1650 (2009).Group, E.T., et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361, 1639-1650 (2009).van Stralen, K.J., Borzych-Dużalka, D., Hataya, H. & et al. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 86(2014).van Stralen, K.J., Borzych-Dużalka, D., Hataya, H. & et al. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 86(2014).Querfeld, U., et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 5, 1642-1648 (2010).Querfeld, U., et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 5, 1642-1648 (2010).Hoy, W.E., et al. The early development of the kidney and implications for future health. Journal of developmental origins of health and disease 1, 216-233 (2010).Hoy, W.E., et al. The early development of the kidney and implications for future health. Journal of developmental origins of health and disease 1, 216-233 (2010).Flynn, J.T., et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 165, 154-162 e151 (2014).Flynn, J.T., et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 165, 154-162 e151 (2014).Rodriguez, M.M., et al. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 7, 17-25 (2004).Rodriguez, M.M., et al. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 7, 17-25 (2004).Abitbol, C.L., et al. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 18, 887-893 (2003).Abitbol, C.L., et al. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 18, 887-893 (2003).Hodgin, J.B., Rasoulpour, M., Markowitz, G.S. & D'Agati, V.D. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4, 71-76 (2009).Hodgin, J.B., Rasoulpour, M., Markowitz, G.S. & D'Agati, V.D. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4, 71-76 (2009).Verhave, J.C., Wetzels, J.F. & van de Kar, N.C. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 29 Suppl 4, iv131-141 (2014).Verhave, J.C., Wetzels, J.F. & van de Kar, N.C. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 29 Suppl 4, iv131-141 (2014).Torres, V.E. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu Rev Med 66, 195-210 (2015).Torres, V.E. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu Rev Med 66, 195-210 (2015).Jarzembowski, T., et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 8, 367-371 (2004).Jarzembowski, T., et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 8, 367-371 (2004).Watson, A.R. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14, 469-472 (2000).Watson, A.R. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14, 469-472 (2000).Aujoulat, I., et al. Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant 15, 148-156 (2011).Aujoulat, I., et al. Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant 15, 148-156 (2011).Watson, A.R., et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int 80, 704-707 (2011).Watson, A.R., et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int 80, 704-707 (2011).Watson, A.R., et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 26, 1753-1757 (2011).Watson, A.R., et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 26, 1753-1757 (2011).Gallieni, M., et al. The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project. TheScientificWorldJournal 2014, 320869 (2014).Gallieni, M., et al. The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project. TheScientificWorldJournal 2014, 320869 (2014).White, A., Wong, W., Sureshkumur, P. & Singh, G. The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease. Journal of paediatrics and child health 46, 504-509 (2010).White, A., Wong, W., Sureshkumur, P. & Singh, G. The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease. Journal of paediatrics and child health 46, 504-509 (2010).Zarocostas, J. Need to increase focus on non-communicable diseases in global health, says WHO. BMJ 341, c7065 (2010).Zarocostas, J. Need to increase focus on non-communicable diseases in global health, says WHO. BMJ 341, c7065 (2010).Gulland, A. WHO agrees to set up body to act on non-communicable diseases. BMJ 346, f3483 (2013).Gulland, A. WHO agrees to set up body to act on non-communicable diseases. BMJ 346, f3483 (2013).Feehally, J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol 8, 12-13 (2011).Feehally, J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol 8, 12-13 (2011).Couser, W.G., Remuzzi, G., Mendis, S. & Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80, 1258-1270 (2011).Couser, W.G., Remuzzi, G., Mendis, S. & Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80, 1258-1270 (2011).

The authors declare that there are no conflicts of interest present.